3.02
Lantern Pharma Inc 주식(LTRN)의 최신 뉴스
Is Lantern Pharma Inc. stock vulnerable to regulatory risksTrade Volume Report & Real-Time Chart Breakout Alerts - newser.com
Is Lantern Pharma Inc. stock oversold or undervaluedJuly 2025 News Drivers & Entry and Exit Point Strategies - newser.com
How Lantern Pharma Inc. stock reacts to global recession fearsMarket Activity Report & Reliable Volume Spike Alerts - newser.com
Can Lantern Pharma Inc. stock deliver consistent earnings growth2025 EndofYear Setup & Proven Capital Preservation Methods - newser.com
Is Lantern Pharma Inc. stock a buy before product launchesTrade Entry Summary & Daily Growth Stock Investment Tips - newser.com
How Lantern Pharma Inc. stock performs in weak economy2025 Winners & Losers & Real-Time Buy Signal Alerts - newser.com
Lantern Pharma Engages New to The Street for National Media Coverage Featuring Television, Press, Earned Media and Non-Deal Investor Focused Roadshows - Gadsden Times
Using economic indicators to assess Lantern Pharma Inc. potentialQuarterly Trade Report & Daily Stock Trend Reports - newser.com
Lantern Pharma (NASDAQ:LTRN) Will Have To Spend Its Cash Wisely - Yahoo Finance
Lantern Pharma Inc. (NASDAQ:LTRN) Q3 2025 Earnings Call Transcript - Insider Monkey
Lantern Pharma’s Earnings Call: Progress and Funding Needs - TipRanks
Lantern Pharma’s Q3 2025: Clinical and AI Progress - TipRanks
Lantern Pharma (NASDAQ: LTRN) Reports Q3 2025 Results and Highlights AI-Driven Clinical Progress - Digital Journal
Transcript : Lantern Pharma Inc., Q3 2025 Earnings Call, Nov 13, 2025 - MarketScreener
Will Lantern Pharma Inc. stock maintain dividend yieldBreakout Watch & Free Risk Controlled Daily Trade Plans - newser.com
LTRN: Pivotal quarter with clinical milestones, AI platform advances, and cash runway into Q3 2026 - TradingView
Earnings call transcript: Lantern Pharma Q3 2025 sees stock rise after earnings - Investing.com India
자본화:
|
볼륨(24시간):